Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040797
Company: INVAGEN PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MEPROBAMATE MEPROBAMATE 200MG TABLET;ORAL Prescription AA No No
MEPROBAMATE MEPROBAMATE 400MG TABLET;ORAL Prescription AA No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/27/2008 ORIG-1 Approval

Label is not available on this site.

MEPROBAMATE

TABLET;ORAL; 200MG
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
MEPROBAMATE MEPROBAMATE 200MG TABLET;ORAL Prescription No AA 090122 ALEMBIC PHARMS LTD
MEPROBAMATE MEPROBAMATE 200MG TABLET;ORAL Prescription No AA 040797 INVAGEN PHARMS

TABLET;ORAL; 400MG
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
MEPROBAMATE MEPROBAMATE 400MG TABLET;ORAL Prescription No AA 090122 ALEMBIC PHARMS LTD
MEPROBAMATE MEPROBAMATE 400MG TABLET;ORAL Prescription No AA 040797 INVAGEN PHARMS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English